Principal Financial Group
BNGO icon

Principal Financial Group’s Bionano Genomics BNGO Stock Holding History

Principal Financial Group’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-127
Closed -$46.6K – 2445
2023
Q2 		$46.6K Sell
127
-5
-4% -$2.26K ﹤0.01% 2365
2023
Q1 		$88.2K Buy
132
+20
+18% +$17.8K ﹤0.01% 2313
2022
Q4 		$97.9K Buy
112
+6
+6% +$7.55K ﹤0.01% 2296
2022
Q3 		$116K Buy
106
+27
+34% +$35.7K ﹤0.01% 2306
2022
Q2 		$66K Sell
79
-1,037
-93% -$1.07M ﹤0.01% 2440
2022
Q1 		$1.73M Sell
1,116
-414
-27% -$559K ﹤0.01% 1887
2021
Q4 		$2.75M Buy
1,530
+1,340
+705% +$3.58M ﹤0.01% 1814
2021
Q3 		$627K Buy
190
+8
+4% +$28K ﹤0.01% 2116
2021
Q2 		$799K Buy
+182
New +$719K ﹤0.01% 2098

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Principal Financial Group's BNGO Position: Q3 2023 in Review

Principal Financial Group sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 127 shares — an estimated $46.6K sold.

Principal Financial Group first reported a position in BNGO in Q2 2021 and held it in 9 quarters. The position peaked at $2.75M in Q4 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • Principal Financial Group reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • Principal Financial Group sold 127 Bionano Genomics shares in Q3 2023, an estimated $46.6K.
  • Principal Financial Group first reported a position in Bionano Genomics in Q2 2021 and held it in 9 quarters.
  • Principal Financial Group's Bionano Genomics position peaked at $2.75M in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Principal Financial Group's 13F filing for Q3 2023, filed 2 Nov 2023.